Chimin Health Management Co., Ltd. (SHA:603222)

China · Delayed Price · Currency is CNY

7.16

+0.16 (2.29%)

Jul 31, 2026, 3:00 PM CST

Chimin Health Management Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	668.04	685.96	775.73	894.51	837.24	1,098
Revenue Growth	-7.63%	-11.57%	-13.28%	6.84%	-23.78%	25.16%
Gross Profit	155.12	168.35	279.6	378.81	386.2	525.88
Operating Income	-158.57	-150.47	-42.06	36.89	86.28	209.16
Net Income	-257.87	-245.58	-59.71	-65.48	34.46	147.52
Earnings Per Share	-0.48	-0.47	-0.11	-0.12	0.07	0.31
EPS Growth	-	-	-	-	-77.42%	2067.83%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Manufacturing	366.51
Medicine Trade	9.09
Medical Services	307.16
Total	682.77

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	282.19	295.28	313.23	361.18	649.31	356.2
Total Debt	773.62	707.65	526.79	481.62	599.81	672.76
Net Cash (Debt)	-491.43	-412.37	-213.56	-120.43	49.5	-316.56
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.91	-0.79	-0.39	-0.22	0.10	-0.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-19.29	-10.35	72.99	140.2	204.65	289.49
Capital Expenditures	-51.52	-46.22	-122.01	-149.22	-196.11	-296.74
Free Cash Flow	-70.8	-56.57	-49.03	-9.02	8.54	-7.25
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	23.22%	24.54%	36.04%	42.35%	46.13%	47.87%
Operating Margin	-23.74%	-21.93%	-5.42%	4.12%	10.31%	19.04%
Pretax Margin	-36.20%	-34.11%	-8.57%	-5.50%	5.13%	15.88%
Profit Margin	-38.60%	-35.80%	-7.70%	-7.32%	4.12%	13.43%
FCF Margin	-10.60%	-8.25%	-6.32%	-1.01%	1.02%	-0.66%

Dividends

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.020	0.064
Dividend Per Share Growth	-68.90%	-
Dividend Yield	0.23%	0.49%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	121.15	42.50
Forward PE	-	50.98	50.98	50.98	50.98	50.98
P/FCF Ratio	-	-	-	-	488.63	-
PS Ratio	5.50	6.96	4.60	4.76	4.99	5.71